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At present the incidence of bronchial asthma on the rise, its pathogenesis 
and the genetic immune and the relationship between social environment 
and other aspects are inseparable the activity of vitamin D (Vit D) in the 
body in the form of 1, 25 - (OH) 2 d3, mainly involved in bone metabolism 
and calcium absorption in addition to this, a growing number of studies 
show that in Vit D plays an important role in the pathogenesis of bronchial 
asthma, play a role in the immune function of bronchial asthma growth 
hormone sensitivity adjustment and airway remodeling in this paper, the 
development of a variety of mechanisms, such as Vit D. Review the pos-
sible mechanisms affecting bronchial asthma, hoping to provide adjuvant 
treatment for patients with bronchial asthma, discover new treatment ap-
















National College students Innovation and Entrepreneurship Project (Project No.: 202011810013). 
1. Function and Metabolism of Vitamin D 
(VitD)
Vit D is a fat-soluble steroid derivative, mainly re-lated to the function of nutritive bones, and is of-ten used to promote and regulate the metabolism 
of calcium and phosphorus in bones [1]. It has been found 
that a large amount of 7-dehydrocholesterol exists in hu-
man skin, and studies have shown that it is the main source 
of VitD[2]. The formation of cutaneous 7-dehydrocholes-
terol (Vit D3) by ultraviolet radiation is followed by the 
production of 25 (OH) D3 by liver 25 hydroxylase and 1, 
25 (OH) 2D3 by kidney 1 hydroxylase. Active VitD ACTS 
on VitD receptors in cells through blood circulation and 
other pathways, and then plays a series of biological roles. 
In addition to the above bone functions, VitD, as an im-
munomodulatory molecule, also has important bone func-
tions such as immunomodulatory, defense and repair [3]. 
In addition, studies have shown that patients with vitamin 
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D deficiency are more likely to cause bronchiectasis, asth-
ma and other lung diseases [4]. In addition, Esfandiar et al. 
found through a large number of clinical investigations 
that the risk of asthma in children with vitamin D defi-
ciency was 3~16 times that of children with normal vita-
min D[5],indicating that vitamin D deficiency increased the 
risk of asthma in children. VitD plays an important role in 
the occurrence and development of asthma.
2. Bronchial Asthma
Bronchial asthma is a chronic inflammation in which the 
respiratory tract cells are damaged, granulocytes are dam-
aged, cells proliferate, lymphocytes and tissue cells are 
damaged. This chronic inflammation leads to hyperres-
ponsiveness of the airways,often with extensive reversible 
airflow limitations, and leads to repeated wheezing, short-
ness of breath, or coughing. The main pathophysiological 
manifestations are chronic airway inflammation andair-
way remodeling, and it is now believed that the change 
of Th1/Th2 cell ratio is the basic mechanism of bronchial 
asthma, especially the most important basis of Th2 cell 
hyperfunction[6]. Bronchial asthma can be divided into 
three levels according to the severity of the disease: light, 
medium and severe. The most common risk groups are 
children or teenagers, people with allergic constitution 
and people with family history of bronchial asthma. In re-
cent years, the role of Vit D as an important treatment for 
bronchial asthma has been gradually recognized, .but the 
specific mechanism of its involvement in asthma has not 
been clarified.
3. VitD ACTS on the Related Mechanism of 
Bronchial Asthma
3.1 VitD ACTS on Th2-mediated Asthma
An important immunological mechanism of asthma is the 
Thl/Th2 imbalance caused by the preponderance of reg-
ulatory lymphocyte responses to Th2 cytokines involved 
in asthma formation[7].Studies have shown that VitD plays 
a certain regulatory role in maintaining Th1 and Th2 
balance and reducing airway inflammation[8]. In addi-
tion,studies have shown that 1,25(OH)2D3,can promote 
the attraction of eosinophils in non-inflammatory sites by 
up-regulating the expression of CXC chemotaxis cytokine 
receptor 4 (CXCR4) on eosinophils[9]. Therefore, when 
VitD is insufficient in human body, the balance of im-
mune Thl/Th2 will shift towards Th2, leading to increased 
synthesis of Th2 cytokines represented by IL-4 and IL-5. 
Because Th2 stimulates B cells to produce specific IgE 
and inflammatory cytokines, which in turn stimulates the 
production of inflammatory mediators, such as eosinophil, 
leading to allergic. reactions in vivo, VitD deficiency may 
lead to airway hyperreactivity (AHR) and asthma[10].
3.2 Vit D Acted on Treg Cells
Treg cells can inhibit excessive immune response, and a 
study has found that Treg cell population is damaged in 
asthma patients, which is directly related to low vitamin 
D level[11]. Forkhead box P3(FoxP3) is a transcription 
factor that plays an important role in T cell development 
and function, and is also involved in the maintenance of 
human autoimmune tolerance. The effect of 1,25-(0H) 
2D3 is to up-regulate the expression of FoxP3 in Treg 
cells, increase the production of il-10, and exert an an-
ti-inflammatory effect by affecting the balance of Th1/
Th2 cells[12],suggesting that vitamin D can promote the 
secretion of il-10. On the contrary, inadequate differentia-
tion and functional defects of Treg cells are the key causes 
of hyperfunction of Th2 cells and asthma[13]. A mouse 
experiment showed that CD4+CD25+Treg cells were sig-
nificantly increased in mice given topical 1,25-(OH) 2D3 
treatment or ultraviolet B(UVB) radiation, and the immu-
nosuppressive effect of CD4+CD25+Treg cells in vivo 
was also significantly enhanced compared with the control 
mice[14]. In addition, vitamin can promote the production 
of Treg cell chemokine CCL22 by myeloid dendritic cells 
and up-regulate the activation of Treg cells[15]. On the con-
trary, inadequate differentiation and functional defects of 
Treg cells are the key causes of hyperfunction of Th2 cells 
and asthma[13]. A mouse experiment showed that CD4+C-
D25+Treg cells were significantly increased in mice given 
topical 1,25-(OH) 2D3 treatment or ultraviolet B(UVB) 
radiation, and the immunosuppressive effect of
CD4+CD25+Treg cells in vivo was also significantly 
enhanced compared with the control mice[14]. In addition, 
vitamin can promote the production of Treg cell chemok-
ine CCL22 by myeloid dendritic cells and up-regulate the 
activation of Treg cells[15].
3.3 VitD ACTS on Th17 Cell Mediated Asthma
In recent years, more and more studies have found that 
Th17/Treg imbalance plays an important role in asthma[16]. 
Pfeffer et al. found that VitD can play an anti-inflamma-
tory role by regulating the response of epithelial cells 
to stimulation[17]. Among them, IL-35 secreted only by 
regulatory T cells has important inhibitory properties on 
cells, especially Th17 cells. Th17 cells secrete IL-6 and 
IL-17, which are involved in the inflammatory response of 
asthma by promoting prostaglandin and acute phase pro-
tein synthesis. 1I1-17 is a proinflammatory cytokine that 
DOI: https://doi.org/10.30564/jams.v3i3.2439 
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can act on airway epithelial cells, etc., and can promote 
the recruitment of neutrophils and macrophages by stim-
ulating chemokines and other cytokines to trigger inflam-
matory responses[18]. In addition, Zhong Jie et al. found 
that SOCS-1 and SOCS-3 were related to Th17/Treg 
imbalance and were associated with allergic asthma. This 
further elucidates the mechanism by which VitD ACTS on 
Th17 cells to mediate asthma[19]. This further elucidates 
the mechanism by which VitD ACTS on Th17 cells to me-
diate asthma.
3.4 Vit D Affects the Sensitivity of Glucocorticoids
The preferred long-term treatment for asthma is inhaled 
corticosteroids (ICS), but long-term use of ICS can con-
tain many side-effects, including inhibiting growth, caus-
ing osteoporosis and lowering the immune system. The 
study of Kelly et al [20] showed that the average height of 
children receiving ICS treatment was 1.2cm lower than 
that of the control group in adult follow-up. To alleviate 
the symptoms of bronchial asthma, ICS activates effective 
anti-inflammatory genes by encoding related cytokines, 
chemokines, and enzymes and receptors involved in in-
flammation[21]. However, it is difficult to control asthma 
symptoms of some patients after long-term use of ICS, 
namely, corticosteroid resistant Asthma (SRA)[22]. On 
the one hand, studies have shown that SRA is related to 
the functional expression of Th17 cells, while Vit D can 
reduce the production of Th17 cells[23]. Vit D can have a 
synergistic effect with ICS in the treatment of bronchial 
asthma, and the mechanism is that Vit D can up-regulate 
the production of ICS-induced IL-10, so as to affect the 
balance of Th1/Th2 cells and thus exert an anti-inflam-
matory effect[24]. On the other hand, the occurrence of 
SRA may include a decrease in the affinity of ICS to its 
receptor[25]. A large number of studies have found that Vit 
D plays an anti-inflammatory role of ICS by down-regu-
lating the expression of NF- B in lymphocytes to enhance 
binding affinity between ICS and hormone receptors[26]. In 
addition, Xiong’s study showed that Vit D can increase the 
expression of MAPK phosphatase 1 activated by mitogen 
and reduce the expression of chemokines, thus reducing 
the phosphorylation of ICS receptors and enhancing the 
anti-inflammatory effect of ICS[27].
3.5 VitD and Respiratory Tract Infection
Respiratory tract infection is an important factor that in-
duces asthma. Vit D is closely related to upper respiratory 
tract infection and can play a role in resisting the invasion 
of respiratory tract pathogens by enhancing the innate im-
munity of human body[28]. The research results of BERRY 
et al. also proved the same conclusion, that when the level 
of 25(OH)D was increased by 4ng/mL, the risk of respira-
tory infection was correspondingly reduced by 7%[29]. In 
addition, VitD can also affect the pathogenesis of asthma 
by influencing; the cell cycle of airway smooth muscle 
(ASM) cells and regulating ASM cells to participate in the 
genetic transcription of airway remodeling.
3.6 Vit D ACTS on Airway Remodeling 
Airway remodeling is an experience of a series of patho-
physiological changes from airway epithelial injury, 
increase of airway smooth muscle cells (ASMCs), and 
angiogenesis during the progression of asthma. No ef-
fective control method is available[30]. Many studies have 
confirmed that in patients with asthma, the expression 
of the nf-kappa B increases significantly and participate 
in the process of airway remodeling, in asthma model 
in mice, Vit D treatment reduced the airway remodel-
ing, reduced the airway of a series of physiological and 
pathological changes, inhibit the nf-kappa B p65 nuclear 
transfer, at the same time by inducing increased I kappa 
alpha B predominate mRNA level and reduce I kappa al-
pha phosphorylation B predominate in order to increase 
the I kappa alpha B protein levels predominate[31]. Cupta 
et al[32] found that the low level of Vit D in children with 
asthma was significantly correlated with the increase of 
ASMCs, which alleviated a series of pathophysiological 
changes in the airway, inhibited the nuclear translocation 
of NF- B P65, and increased the level of I B protein by in-
ducing increased I B mRNA levels and reduced I B phos-
phorylation[31]. Cupta[34] et al. found that  the low level of 
Vit D in asthmatic children was significantly correlated 
with the increase of ASMCs, which alleviated a series of 
pathophysiological changes in the airway, inhibited the 
nuclear translocation of NF- B P65,and increased the level 
of I B protein by inducing increased I B mRNA levels and 
reduced I B phosphorylation[31]. Cupta[32] et al. found that 
the low level of Vit D in children with asthma was signifi-
cantly correlated with the increase of ASMCs, which al-
leviated a series of pathophysiological changes in the air-
way, inhibited the nuclear translocation of NF- B P65, and 
increased the level of I B protein by inducing increased I 
B mRNA levels and reduced I B phosphorylation[31].Cupta 
et al.[32] found that the low level of Vit D in children with 
asthma was significantly correlated with the increase of 
ASMCs, which alleviated a series of pathophysiological 
changes in the airway, inhibited the nuclear translocation 
of NF- B P65,and increased the level of I B protein by in-
ducing increased I B mRNA levels and reduced I B phos-
phorylation[31]. Cupta et al. [32] found that the low level of 
Vit D in children with asthma was significantly correlated 
DOI: https://doi.org/10.30564/jams.v3i3.2439 
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with the increase of ASMCs. 1,25-(OH) 2D3 can reduce 
the proliferation of ASMCs by inhibiting the phosphory-
lation of retinoblastoma protein (Rb) and cell cycle mon-
itoring point kinase 1(Chk1)[33]. Vit D can down-regulate 
the expression and mRNA levels of the two proteases in 
ASMCs sensitized by Adistintegrin and metalloproteinase 
33, ADAM33 and matrix metalloproteinase9, MMP9,and 
effectively inhibit ASMAS proliferation[34]. 
4. Conclusion
As an immunomodulator, Vit D may inhibit the pathways 
involved in the occurrence and development of asthma, 
thus playing a certain role in the occurrence and develop-
ment of bronchial asthma. Qu Jumei et al. showed that the 
level of Vit D in children with bronchial asthma was sig-
nificantly lower. After supplementing with Vit D, asthma 
symptoms were significantly relieved[35],which further ver-
ified the close relationship between vitamin D and bron-
chial asthma. Therefore, the revelation of the mechanism 
of Vit D’s influence on asthma opens up a new horizon for 
the treatment of asthma.
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